Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Edible seeds from the Cucurbitaceae family like pumpkin and watermelon seeds are nutritious and may have health benefits, but eating too much can cause side effects.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Using steroids can increase the risk of heart problems.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

The study found stem cells in minor salivary glands that can differentiate and are involved in tumor formation when exposed to tobacco.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.